Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock

Pediatric Critical Care Medicine

Volumn 11, Issue 2, 2010, Pages 213-216

  Nowak, Jeffrey E ^a   Wheeler, Derek S ^a   Harmon, Kelli K ^a   Wong, Hector R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Biological markers; Chemokine CCL4; Clinical trials as topic; Pediatrics; Sepsis; Septic; Shock

Indexed keywords

BIOLOGICAL MARKER; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERFORMANCE; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SERUM; SURVIVAL; UNITED STATES;

EID: 77949454402     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181b8076c     Document Type: Article

References (16)

1. Watson RS, Carcillo JA, Linde-Zwirble WT, et al: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701
2. Watson RS, Carcillo JA: Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med 2005; 6:S3-S5
3. Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003. Crit Care Med 2007; 35:1244-1250
4. Whitley E, Ball J: Statistics review 4: Sample size calculations. Crit Care 2002; 6:335-341
5. Marshall JC, Vincent J, Fink MP, et al: Measures, markers, and mediators: Toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med 2003; 31:1560-1567
6. Wong HR, Shanley TP, Sakthivel B, et al: Genome-level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 2007; 30:146-155
7. Shanley TP, Cvijanovich N, Lin R, et al: Genome- level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007; 13:495-508
8. Wong HR: Pediatric septic shock treatment: New clues from genomic profiling. Pharmacogenomics 2007; 8:1287-1290
9. Goldstein B, Giroir B, Randolph A: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2-8
10. Menten P, Wuyts A, Van Damme J: Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002; 13:455-481
11. Maurer M, von Stebut E: Macrophage inflammatory protein-1. Int J Biochem Cell Biol 2004; 36:1882-1886
12. O'Grady NP, Tropea M, Preas HL, et al: Detection of macrophage inflammatory protein (MIP)-1alpha and MIP-1beta during experimental endotoxemia and human sepsis. J Infect Dis 1999; 179:136-141
13. Hutchinson KL, Rollin PE: Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis 2007; 196(Suppl 2):S357-S363
14. John CC, Opika-Opoka R, Byarugaba J, et al: Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis 2006; 194:837-845
15. Wong HR, Cvijanovich N, Wheeler DS, et al: Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008; 178:276-282
16. Marcin JP, Pollack MM, Patel KM, et al: Decision support issues using a physiology based score. Intensive Care Med 1998; 24: 1299-1304